NCT05253248 (OMIS) is a NA clinical trial of OMIS in Micronutrients Reference Interval, sponsored by Dr Konstantinos Gerasimidis.

Who is sponsoring NCT05253248?

NCT05253248 is sponsored by Dr Konstantinos Gerasimidis.

What drugs are being tested in NCT05253248?

Interventions in NCT05253248: OMIS.

What condition does NCT05253248 study?

NCT05253248 studies Micronutrients Reference Interval, Micronutrients Normal Range.

Is NCT05253248 still recruiting?

NCT05253248 is currently completed. Last updated 1 November 2022.

Last reviewed 2022-11-01 · How we verify

NCT05253248: OMIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development of an Optimal Micronutrient Reference Range for Adults

Completed NA Last updated 1 November 2022

What this trial tests

NA trial testing OMIS in Micronutrients Reference Interval in 141 participants. Completed in 30 August 2022.

Timeline

1 May 2018

Primary endpoint
30 August 2022

30 August 2022

Quick facts

Lead sponsor	Dr Konstantinos Gerasimidis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	141
Start date	1 May 2018
Primary completion	30 August 2022
Estimated completion	30 August 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

OMIS

Conditions studied

Micronutrients Reference Interval — all drugs for Micronutrients Reference Interval →
Micronutrients Normal Range — all drugs for Micronutrients Normal Range →

Sponsor

Dr Konstantinos Gerasimidis

Who can join

Adults 18 to 65, any sex, with Micronutrients Reference Interval or Micronutrients Normal Range. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to develop optimal micronutrient reference intervals from blood samples collected from "ideal" healthy adults and following micronutrient supplementation to minimise the chance of subclinical deficiencies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05253248 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr Konstantinos Gerasimidis
Last refreshed: 1 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05253248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing